COVID-19 Vaccination in Kidney Transplant Recipients: An Ounce Pre-Transplant is Worth a Pound Post-Transplant.
作者信息
Chandran Sindhu, Stock Peter G
机构信息
Department of Medicine, University of California, San Francisco.
Department of Surgery, University of California, San Francisco.
出版信息
J Am Soc Nephrol. 2021 Dec 1;32(12):2977-2978. doi: 10.1681/ASN.2021101347.
Abstract
摘要
相似文献
1
COVID-19 Vaccination in Kidney Transplant Recipients: An Ounce Pre-Transplant is Worth a Pound Post-Transplant.
J Am Soc Nephrol. 2021 Dec 1;32(12):2977-2978. doi: 10.1681/ASN.2021101347.
2
Renal Complications in Kidney Transplant Recipients After Whole-virus Inactivated COVID-19 Vaccination.
Transplantation. 2022 Nov 1;106(11):e510-e511. doi: 10.1097/TP.0000000000004330. Epub 2022 Sep 19.
3
COVID-19 vaccination in kidney transplant recipients.
Nat Rev Nephrol. 2021 Dec;17(12):785-787. doi: 10.1038/s41581-021-00491-7.
4
SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?
J Am Soc Nephrol. 2022 Apr;33(4):869-870. doi: 10.1681/ASN.2021121566. Epub 2022 Feb 14.
5
Humoral Response After 5 Successive Doses of COVID-19 Vaccine in Kidney Transplant Patients: Comment.
Transplantation. 2023 Nov 1;107(11):e319. doi: 10.1097/TP.0000000000004756. Epub 2023 Oct 21.
6
Authors' Reply: SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?
J Am Soc Nephrol. 2022 Apr;33(4):870-871. doi: 10.1681/ASN.2022010033. Epub 2022 Feb 14.
7
Humoral Response After Five Successive Doses of SARS-CoV-2 mRNA Vaccine in Kidney Transplant Patients.
Transplantation. 2023 Jul 1;107(7):e188-e189. doi: 10.1097/TP.0000000000004628. Epub 2023 May 12.
8
Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.
Transplant Proc. 2022 Nov;54(9):2454-2456. doi: 10.1016/j.transproceed.2022.09.019. Epub 2022 Oct 3.
9
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
J Am Soc Nephrol. 2021 Sep;32(9):2153-2158. doi: 10.1681/ASN.2021040490. Epub 2021 Jun 16.
10
Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.
Clin Exp Nephrol. 2023 Jan;27(1):98-99. doi: 10.1007/s10157-022-02261-6. Epub 2022 Aug 5.
引用本文的文献
1
Effects of anti-SARS-CoV-2 vaccination in living kidney transplant recipients prior to transplantation.
Clin Exp Nephrol. 2024 Dec;28(12):1332-1333. doi: 10.1007/s10157-024-02535-1. Epub 2024 Jul 6.
2
Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech.
Vaccines (Basel). 2024 Jan 17;12(1):91. doi: 10.3390/vaccines12010091.
3
Literature review on COVID-19 vaccine efficacy in the immunocompromised population, and possible implications to future vaccination in kidney transplant patients.
Front Med (Lausanne). 2023 Feb 2;10:1103699. doi: 10.3389/fmed.2023.1103699. eCollection 2023.
4
Management of COVID-19 in Kidney Transplant Recipients: A Single-Center Case Series.
Int J Nephrol. 2022 Aug 18;2022:9636624. doi: 10.1155/2022/9636624. eCollection 2022.
本文引用的文献
1
B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.
J Am Soc Nephrol. 2021 Dec 1;32(12):3027-3033. doi: 10.1681/ASN.2021070966.
2
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.
Ann Rheum Dis. 2022 Feb;81(2):293-295. doi: 10.1136/annrheumdis-2021-221252. Epub 2021 Sep 23.
3
Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.
Am J Transplant. 2022 Feb;22(2):634-639. doi: 10.1111/ajt.16851. Epub 2021 Nov 1.
4
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse.
Kidney Int. 2021 Nov;100(5):1135-1136. doi: 10.1016/j.kint.2021.09.001. Epub 2021 Sep 9.
5
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients.
Am J Transplant. 2021 Dec;21(12):3990-4002. doi: 10.1111/ajt.16818. Epub 2021 Sep 6.
6
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.
7
SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine.
JAMA Netw Open. 2021 Aug 2;4(8):e2119741. doi: 10.1001/jamanetworkopen.2021.19741.
8
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.
Am J Transplant. 2021 Nov;21(11):3808-3810. doi: 10.1111/ajt.16764. Epub 2021 Jul 23.
9
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.
Sci Immunol. 2021 Jun 15;6(60). doi: 10.1126/sciimmunol.abj1031.
10
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
J Clin Invest. 2021 Jul 15;131(14). doi: 10.1172/JCI150175.
Zotero 插件